| |
|
|
|
Antares Pharma Inc.  
|
|
3.2825 0.033 (0.01%) |
11-21 11:19 |
|
Open: |
3.27 |
Pre close: |
3.25 |
Target:
|
4.05
|
|
High: |
3.32 |
Low: |
3.25 |
Resistance:
|
3.47
3.78
|
|
Volume: |
132,726 |
Market Cap: |
517M |
Support:
|
2.96
2.46
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.32
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
3.36  |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
3.22 |
Stochastic Oscillator |
%K(14,3):
|
37.69 |
|
MA(250): |
2.67 |
%D(3): |
43.05 |
|
Average Volume(K) |
3-Month: |
160589
|
52-Week |
High:
|
3.93 |
|
10-Days: |
96586 |
Low: |
1.68 |
|
RSI |
RSI(14):
|
44.78 |
Change(%): |
77.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.100 |
Return on Equity (ttm) |
-54.2 |
Shares Out. (M) |
157.54 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
-21.4 |
Shares Float (M) |
141.82 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
-0.43 |
% Held by Insiders |
10.00 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
18.7 |
% Held by Institutions |
57.60 |
|
Forward EPS |
0.050 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
21.980 |
EBITDA (p.s.) |
0.000 |
P/E |
-32.70 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.15 |
|
Profit Margin |
-33.10 |
Operating Cash Flow
(M) |
-17.77 |
P/S |
1392312960.00 |
|
Operating Margin |
-25.37 |
Levered Free Cash Flow
(M) |
-4.99 |
P/CF |
-28.99 |
|
|
|
|
|
|
